LUMYKRAS 120 mg film-coated tablets, LUMYKRAS 240 mg film-coated tablets
DCC-3116-01-001
Phase 2 small_molecule active
Quick answer
LUMYKRAS 120 mg film-coated tablets, LUMYKRAS 240 mg film-coated tablets for Non-Small Cell Lung Cancer, Metastatic Solid Tumor, Advanced Solid Tumor is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Non-Small Cell Lung Cancer, Metastatic Solid Tumor, Advanced Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active